Nuclidium
Latest round
- Series B
Last raised
- May 2026
Total raised
- $132M
Investors
- 12
About Nuclidium
Founded in 2017 and based in Basel, Switzerland, Nuclidium AG, formerly known as Swiss Nuclides AG, operates as a biopharmaceutical company that develops and manufactures drugs for the treatment of cancer. Leila Jaafar (CEO) and Gustav von Schulthess are the co-founders of the company. The company offers CuTrace™ platform, which integrates copper radiometals with a variety of cancer-targeting compounds to generate novel therapeutic and diagnostic solutions. Nuclidium’s pipeline include NuriPro ™ for prostate cancer, TraceNET ™ for neuroendocrine tumors, Kalios ™ for colorectal, gastric, and lobular breast cancer, CuNeo ™ for ductal breast and lung cancer, and AlphaFlare ™ for head and neck pancreatic cancer. The firm’s pipeline comprises of tumor indications and copper-based radiopharmaceuticals.
Who invested in Nuclidium
12 investors across 3 rounds
See all investors in Nuclidium
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nuclidium
Who invested in Nuclidium?
Nuclidium has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuclidium raised?
Nuclidium has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Nuclidium last raise money?
Nuclidium's most recent round on record is a Series B, in May 2026.
What does Nuclidium do?
Founded in 2017 and based in Basel, Switzerland, Nuclidium AG, formerly known as Swiss Nuclides AG, operates as a biopharmaceutical company that develops and manufactures drugs for the treatment of cancer.
Where is Nuclidium headquartered?
Nuclidium is headquartered in Basel, Switzerland.
Which VCs invest in companies like Nuclidium?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Nuclidium's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Nuclidium? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.